– Seventh approved indication for RINVOQ in the European Union (EU) and the first and only oral Janus Kinase (JAK) inhibitor approved to treat adult patients with moderately to severely active Crohn’s disease – Third gastroenterology indication approved across AbbVie’s Inflammatory Bowel…